as 12-23-2024 4:00pm EST
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
Founded: | 1992 | Country: | United States |
Employees: | N/A | City: | WARRINGTON |
Market Cap: | 2.9M | IPO Year: | 1995 |
Target Price: | $7.00 | AVG Volume (30 days): | 1.2M |
Analyst Decision: | Hold | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -19.21 | EPS Growth: | N/A |
52 Week Low/High: | $0.32 - $14.75 | Next Earning Date: | 11-27-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
WINT Breaking Stock News: Dive into WINT Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
GlobeNewswire
15 days ago
MT Newswires
19 days ago
MT Newswires
19 days ago
GlobeNewswire
20 days ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
Zacks Small Cap Research
a month ago
The information presented on this page, "WINT Windtree Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.